Last reviewed · How we verify
Adapalene 0.1% gel plus clindamycin 1% gel
Adapalene 0.1% gel plus clindamycin 1% gel is a Small molecule drug developed by All India Institute of Medical Sciences, Bhubaneswar. It is currently FDA-approved.
At a glance
| Generic name | Adapalene 0.1% gel plus clindamycin 1% gel |
|---|---|
| Sponsor | All India Institute of Medical Sciences, Bhubaneswar |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Experience With Topical Acne Treatment (EARLY_PHASE1)
- Compound Adapalene and Clindamycin Hydrochloride Gel in Treatment of Patients With Acne (PHASE1, PHASE2)
- DUAC® Early Onset Efficacy Study in Japanese Subjects (PHASE4)
- Tazarotene Plus Clindamycin vs. Adapalene Plus Clindamycin in the Treatment of Facial Acne Vulgaris (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Adapalene 0.1% gel plus clindamycin 1% gel CI brief — competitive landscape report
- Adapalene 0.1% gel plus clindamycin 1% gel updates RSS · CI watch RSS
- All India Institute of Medical Sciences, Bhubaneswar portfolio CI
Frequently asked questions about Adapalene 0.1% gel plus clindamycin 1% gel
What is Adapalene 0.1% gel plus clindamycin 1% gel?
Adapalene 0.1% gel plus clindamycin 1% gel is a Small molecule drug developed by All India Institute of Medical Sciences, Bhubaneswar.
Who makes Adapalene 0.1% gel plus clindamycin 1% gel?
Adapalene 0.1% gel plus clindamycin 1% gel is developed and marketed by All India Institute of Medical Sciences, Bhubaneswar (see full All India Institute of Medical Sciences, Bhubaneswar pipeline at /company/all-india-institute-of-medical-sciences-bhubaneswar).
What development phase is Adapalene 0.1% gel plus clindamycin 1% gel in?
Adapalene 0.1% gel plus clindamycin 1% gel is FDA-approved (marketed).